Market Tracker

11/28 9:11am ET

ImmuCell Corp (NASDAQ:ICCC)

4.90
Data as of Nov 26
 +0.05 / +1.03%
Today’s Change
3.30
Today|||52-Week Range
5.68
+14.78%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close4.85
Today’s open4.80
Day’s range-- - --
Volume2,212
Average volume (3 months)2,938
Market cap$14.8M
Dividend yield--
Data as of 11/26/2014

Growth & Valuation

Earnings growth (last year)+33.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+11.45%
P/E ratioNM
Price/Sales2.15
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
CBMXCombiMatrix Corp0.000.00%
--Cell Source Inc0.000.00%
GENEGenetic Technologies...+0.03+6.63%
CMXCCell MedX Corp-0.01-1.39%
Data as of 11/26/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$6.0M
Annual profit (last year)$117.4K
Net profit margin1.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Treasurer
Michael F. Brigham
Director, Chief Scientific Officer &
VP
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts